Bristol Myers Squibb (CELG-RI) Minority Interest (2009 - 2026)

Bristol Myers Squibb has disclosed Minority Interest across 18 years of filings, most recently posting $34.0 million for Q1 2026.

• In Q1 2026, Minority Interest fell 42.37% year-over-year to $34.0 million; the TTM figure through Mar 2026 stood at $34.0 million (down 42.37% YoY), while the FY2025 annual figure was $33.0 million, down 37.74% from the prior year.
• Minority Interest rose to $34.0 million in Q1 2026, from $33.0 million in the prior quarter.
• Over the last five years, Minority Interest for CELG-RI reached as high as $65.0 million in Q1 2022 and fell as low as $33.0 million in Q4 2025.
• The 5-year median for Minority Interest is $57.0 million (2022), against an average of $55.0 million.
• Annual changes were most pronounced in 2025 — Minority Interest climbed 1.72% — and 2026, when it slumped 42.37%.
• A 5-year view of Minority Interest shows it stood at $57.0 million in 2022, then fell by 3.51% to $55.0 million in 2023, then dropped by 3.64% to $53.0 million in 2024, then slumped by 37.74% to $33.0 million in 2025, then rose by 3.03% to $34.0 million in 2026.
• According to Business Quant data, Minority Interest over the past three periods registered $34.0 million, $33.0 million, and $48.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.